CGON in the 13F filings
CG Oncology Inc · CUSIP 156944100
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 18
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 3 listed it in both
- Shares listed
- 15,721,562
- combined, among listed positions
- Reported value
- $1.1bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 12 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -581,181.
Managers listing CGON in Q2 2026
18 of 18 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 4,161,493 shares now+396,649
- T. Rowe Price Associates Incexisting position · 3,805,010 shares now+152,030
- AllianceBernstein LPexisting position · 1,374,149 shares now+84,062
- Man Group PLCnew position · 51,849 shares now+51,849
- D. E. Shaw & Co.existing position · 89,417 shares now+42,807
Reductions
- Wellington Management Group LLPexisting position · 5,324,751 shares now-46,481
- Invesco Ltdexisting position · 52,406 shares now-39,588
- AQR Capital Management LLCexisting position · 102,397 shares now-11,945
- Susquehanna International Group LLPexisting position · 15,653 shares now-10,150
- Quantbot Technologies LPexisting position · 113 shares now-2,770
New positions and exits
New (5)
- Man Group PLC$3.7m
- Squarepoint Ops LLC$1.0m
- Winton Group Ltd$718k
- Marshall Wace LLP$297k
- Neuberger Berman Group LLC$211k
Exited (7)
- Farallon Capital Management LLCwas $46m
- Point72 Asset Management LPwas $27m
- Citadel Advisors LLCwas $12m
- Brevan Howard Capital Management LPwas $785k
- PDT Partners LLCwas $757k
- Hudson Bay Capital Management LPwas $506k
- Jane Street Group LLCwas $210k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2024 | 3 | $123m | 3 | 0 |
| Q2 2024 | 2 | $62m | 0 | 1 |
| Q3 2024 | 3 | $103m | 3 | 0 |
| Q4 2024 | 3 | $102m | 2 | 1 |
| Q1 2025 | 5 | $154m | 4 | 1 |
| Q2 2025 | 4 | $57m | 2 | 3 |
| Q3 2025 | 6 | $394m | 2 | 3 |
| Q4 2025 | 4 | $272m | 9 | 7 |
| Q1 2026 | 5 | $690m | 13 | 9 |
| Q2 2026 | 4 | $777m | 12 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
CGON and GILD →CGON and AMGN →CGON and ARGX →Choose a stock to compare with CGON →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own CGON, latest filings →Back to the 13F Explorer →